Results 51 to 60 of about 56,087 (242)

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone [PDF]

open access: hybrid, 2021
Thomas Römer   +11 more
openalex   +1 more source

BEBERAPA FAKTOR YANG BERKAITAN DENGAN PEMILIHAN TYPE ALAT KONTRSEPSI SUNTIK PADA IBU MENYUSUI DI KECAMATAN GENUK,BULAN JUNI 2003 [PDF]

open access: yes, 2003
Penelitian yang dilakukan oleh Sindhung (1999) menyebutkan bahwa faktor-faktor yang mempengaruhi penggunaan alat kontrasepsi diantaranya adalah Pengetahuan, Informasi, umur, Sosial ekonomi serta dukungan tohok masyarakat / keluarga. Hal ini sesuai dengan
PRIHATMIATI K , ATIEK
core  

WISDOM: history and early demise - was it inevitable?

open access: yes, 2007
In 1989, the UK Medical Research Council (MRC) agreed that, if feasible, a randomized controlled trial to assess the long-term risks and benefits of hormone replacement therapy (HRT) was a priority.
Darbyshire, J, Meade, T, Vickers, M
core   +1 more source

High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin

open access: yesBiomedicines, 2022
The widely reported conflicting effects of progestin on breast cancer suggest that the progesterone receptor (PR) has dual functions depending on the cellular context.
Natasa Bajalovic   +4 more
doaj   +1 more source

Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis

open access: yesFrontiers in Oncology
ObjectivesThe objective of this network meta-analysis is to systematically compare the efficacy of diverse progestin-based combination regimens in treating patients diagnosed with endometrial cancer or atypical endometrial hyperplasia.
Jie Cui   +3 more
doaj   +1 more source

Hormone replacement therapy [PDF]

open access: yes, 2012
Martha Hickey, Jane Elliott, Sonia Louise ...
Davison, S., Elliott, C., Hickey, M.
core   +2 more sources

Verification of the utility of the gonadotropin starting dose calculator in progestin‐primed ovarian stimulation: A comparison of empirical and calculated controlled ovarian stimulation

open access: yesReproductive Medicine and Biology
Purpose To validate the effectiveness of a gonadotropin starting dose calculator for progestin‐primed ovarian stimulation (PPOS), we conducted a study comparing the outcomes of oocyte retrieval between a group assigned gonadotropin doses via the ...
Masato Kobanawa, Jouji Yoshida
doaj   +1 more source

Modeling county level breast cancer survival data using a covariate-adjusted frailty proportional hazards model

open access: yes, 2015
Understanding the factors that explain differences in survival times is an important issue for establishing policies to improve national health systems.
Hanson, Timothy   +3 more
core   +1 more source

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis [PDF]

open access: yes, 2002
Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated whether this risk is affected by carriership of hereditary prothrombotic abnormalities.
A. Rumley   +26 more
core   +1 more source

Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation

open access: yesMolecular Autism, 2018
Background Recent literatures indicate that maternal hormone exposure is a risk factor for autism spectrum disorder (ASD). We hypothesize that prenatal progestin exposure may counteract the neuroprotective effect of estrogen and contribute to ASD ...
Weiguo Xie   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy